TY - CHAP M1 - Book, Section TI - Uterine Sarcomas A1 - Leiserowitz, Gary S. A2 - Karlan, Beth Y. A2 - Bristow, Robert E. A2 - Li, Andrew J. PY - 2015 T2 - Gynecologic Oncology: Clinical Practice and Surgical Atlas AB - Sarcomas comprise approximately 3% to 7% of uterine corpus malignancies. Although they represent a small proportion of uterine cancers, they disproportionately contribute to mortality. Their biologic behaviors are highly variable, ranging from a locally invasive process with minimal metastatic risk to highly aggressive tumors that are characterized by intra-abdominal or disseminated hematogenous spread. This reflects the complex origin of the malignant tissue components: endometrium, endometrial stroma, and smooth muscle, plus supportive elements of the uterine corpus. SN - PB - McGraw-Hill Medical CY - New York, NY Y2 - 2024/03/28 UR - obgyn.mhmedical.com/content.aspx?aid=1106570371 ER -